论文部分内容阅读
Objective Advanced gastric cancer is a common and fatal disease,and it is still the second leading cause of cancer-related deaths worldwide despite decline in its incidence and mortality in recent years.In patients with stages Ⅲ and Ⅳ gastric cancer,the 5-year overall survival(OS)rates are poor.